Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Introduced at the First Clinical Visit: A Real-Life Single-Arm Single-center Retrospective Cohort Study
In our real-life clinical setting, same-day treatment with BIC/FTC/TAF was an efficacious and feasible option for achieving viral suppression in treatment-naïve PLWH.
Authors
- Iva Lisičar (ORCID: https://orcid.org/0000-0002-8396-909X)
- Snježana Židovec Lepej (ORCID: https://orcid.org/0000-0001-9852-5806)
- Josip Begovać (ORCID: https://orcid.org/0000-0003-2641-4327)
- Vanja Romih Pintar
- Šime Zekan (ORCID: https://orcid.org/0000-0002-5987-3960)
- Ana Planinić
Institutions
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1007/s40121-025-01139-w
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Hrvatska Zaklada za Znanost